Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs NXP Semiconductors N.V. Common Stock (NXPI) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
NXP Semiconductors N.V. Common StockTrade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs NXP Semiconductors N.V. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 4.6× Halozyme Therapeutics Inc. Common Stock's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and NXP Semiconductors N.V. Common Stock for 0 Days on average.

HALONXPI
Market Cap
$12.58B$58.27B
Volume
2,179,2783,950,702
Sector
HealthTechnology
52-Week High
$115.22$332.67
52-Week Low
$61.63$184.19
Typical Hold Time
1 Days0 Days
Enterprise Value
$14.49B$66.38B
Dividend Yield
—1.76%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HALO

No sentiment data available yet.

NXPI
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About NXP Semiconductors N.V. Common Stock

NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.

Read more on NXPI →